Integrated therapy of advanced melanoma.

被引：0
|
作者：
Vitello, S
Scuderi, G
机构：
[1] Osped S Elia Caltanissetta, Serv Oncol, Caltanissetta, Italy
[2] Osped S Elia Caltanissetta, Reparto Dermatol, Caltanissetta, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
G23
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [41] Combined modality therapy for patients with nodal metastases from melanoma.
    Ballo, MT
    Ross, MI
    Cormier, JN
    Myers, JN
    Gershenwald, JE
    Lee, JE
    Zagars, GK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 714S - 714S
  • [42] Myelodysplastic syndromes after fotemustine and dacarbazine therapy for malignant melanoma.
    Perrot, JL
    Lanthier, K
    Benoit, F
    Graille, MC
    Guy, C
    Bertheas, MF
    Cambazard, F
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1995, 122 (10): : 663 - 666
  • [43] BRAF and NRAS mutation status and response to checkpoint inhibition in advanced melanoma.
    van Not, Olivier Jules
    van den Eertwegh, Alfonsus Johannes Maria
    Haanen, John B. A. G.
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette
    de Groot, Jan Willem
    Hospers, Geke
    Kapiteijn, Ellen
    Piersma, Djura
    Van Rijn, Rozemarijn
    Stevense, Marion
    Van Der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Boers-Sonderen, Marye
    Bonenkamp, Han J.
    Jansen, Anne M. L.
    Blokx, Willeke
    Wouters, Michel W. J. M.
    Suijkerbuijk, Karijn
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Single-center experience with ipilimumab in patients with pretreated advanced melanoma.
    Wilgenhof, Sofie
    Seghers, Amelie Clementine
    Du Four, Stephanie
    Lienard, Danielle
    Salmon, Isabelle
    Del Marmol, Veronique
    Neyns, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Mechanisms of elevated serum creatinine in patients receiving vemurafenib for advanced melanoma.
    Hurabielle, Charlotte
    Pillebout, Evangeline
    Stehle, Thomas
    Pages, Cecile
    Roux, Jennifer
    Schneider, Pierre
    Chevret, Sylvie
    Mourah, Samia
    Basset-Seguin, Nicole
    Chaffaut, Cendrine
    Vidal-Petiot, Emmanuelle
    Flamant, Martin
    Lebbe, Celeste
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] IMPROVED LOCAL CONTROL WITH NEW MULTIMODAL THERAPY FOR ANAL MELANOMA.
    Domek, K. P.
    Bradney, L. A.
    Mahmoud, F.
    Konda, M.
    Atwal, D.
    Mizell, J.
    DISEASES OF THE COLON & RECTUM, 2018, 61 (05) : E194 - E195
  • [47] Phase Ib/II trial of lenvatinib plus pembrolizumab in advanced melanoma.
    Taylor, Matthew H.
    Vogelzang, Nicholas J.
    Cohn, Allen Lee
    Stepan, Daniel E.
    Shumaker, Robert Charles
    Dutcus, Corina E.
    Guo, Matthew
    Schmidt, Emmett V.
    Rasco, Drew W.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [48] Evaluation of the clinical benefits of immune checkpoint inhibitors in patients with advanced melanoma.
    Ou, Qiyun
    Yu, Yunfang
    Lin, Dagui
    Fu, Tuping
    Gao, Quanlong
    Luo, Baoming
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [49] Management of Melanoma. Diagnosis Position - Therapy - After-care
    Adib-Tezer, H.
    AKTUELLE DERMATOLOGIE, 2007, 33 (05) : 163 - 163
  • [50] Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma.
    Stoff, Ronen
    Markovic, Svetomir
    McWilliams, Robert R.
    Yan, Yiyi
    Tan, Winston
    Seetharam, Mahesh
    Block, Matthew Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345